International Clinical Trial: Clinical study on predicting the response of lung cancer immunotherapy through drug testing by integrating quantitative systems pharmacology and twin technology

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128496) titled 'Clinical study on predicting the response of lung cancer immunotherapy through drug testing by integrating quantitative systems pharmacology and twin technology' on July 21.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Sun Yat-sen University Cancer Center

Condition: advanced lung cancer trial subjects /patients

Intervention: Safety indicators:None

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-08-01

Target Sample Size: Safety indicators:300;QSP - Digital Twin Model Virtual Patient Group:300;

Countries of Recruitment: China

To know more, vi...